| ||
News from SGC
The SGC-CHDI open access patent-free partnership for Huntington’s disease research has been selected as a featured Innovator to present on November 17th at the 6th annual Partnering for Cures meeting in New York City, NY. The conference will bring together nearly 1,000 medical research leaders, investors and decision-makers to forge the collaborations needed to speed and improve outcomes-driven R&D.
2014 is the International Year of Crystallography and to celebrate this event NDM has produced a series of short films.
‘Revolutionary Biology’: Revolutionary Biology shows how the field of structural biology has developed over the past 100 years, Oxford’s involvement in that development, and where we go from here.
SGC Toronto will hold a free workshop ‘EZH2 Inhibitors: Target Validation through Chemical Biology’, on February 9th, 2015 at the Princess Margaret Cancer Centre in Toronto, ON.
The goal of this event is to share practical knowledge gained using EZH2 inhibitors in various cellular and in vivo systems. In the spirit of sharing information, this workshop will be highly interactive.
The workshop will feature presentations from scientists in academia and industry. Participants are encouraged to submit posters from which 3-4 will be chosen for short oral presentations.
Sarah Dixon-Clarke, born in the UK, joined the University of Oxford in 2011 after studying Biological Sciences and Biochemistry at the University of St Andrews. Sarah is affiliated with University College and works on structure-function analysis of the extended cyclin-dependent kinase family under the supervision of Dr Alex Bullock.
"Making pharmaceutical research more open could shave years off the time it takes to bring a new drug to market".
SGC's commitment to accelerating drug discovery is profiled by John Lorinc in the University of Toronto Magazine.
On Friday August 22nd, 2014, sixteen members of SGC at University of Toronto completed the ALS Ice Bucket Challenge outside the MaRS building (video here). As part of the challenge, SGC's Director, Aled Edwards nominated Takeda's General Manager Tetsu Maruyama. In a video released today, Dr Maruyama responded along with seven of his Takeda colleagues.
Takeda has been a partner of the consortium since 2012.
In addition to completing the Ice Bucket Challenge, SGC-Toronto has raised $1,200 for ALS Canada.
The Structural Genomics Consortium in Toronto hosted ChemNET's first Bootcamp for the 2013-2015 trainees.
ChemNET is an NSERC CREATE training program that provides Chemistry graduate students and post-doctoral fellows the opportunity to gain practical medicinal and biological chemistry experience developing chemical probes for epigenetic proteins in collaboration with the pharmaceutical industry. All of ChemNET's output is open access and will be placed in the public domain with no restrictions.